results

Zelluna ASA Reports Second Quarter 2025 Financial Results and Provides General Business Update

Oslo, Norway, 20 August 2025 – Zelluna (OSE: ZLNA), a company pioneering allogeneic “off-the-shelf” T-cell receptor-based natural killer (TCR-NK) therapies…

3 weeks ago

No Drag. Just Drive. Vectorworks 2026 Coming Soon

Upcoming Version of the Design and BIM Software Empowers Designers with Smarter Automation, Seamless Customization, and Sustainability Insights. COLUMBIA, Md.,…

3 weeks ago

FUN Investors Have Opportunity to Join Six Flags Entertainment Corporation Fraud Investigation With the Schall Law Firm

LOS ANGELES--(BUSINESS WIRE)--$FUN--The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf…

3 weeks ago

Sustaining Operational Excellence and Financial Strength, Nava Advances on Strategic Growth Projects

HYDERABAD, India, Aug. 14, 2025 /PRNewswire/ -- NAVA Limited, a diversified Indian multinational conglomerate operating across Metals, Mining, Energy, Commercial Agriculture,…

3 weeks ago

CNRC Reports Q2 2025 Financials Period Ending June 30, 2025; Provides Shareholder Update on Portfolio Companies

CHARLESTON, W.Va., Aug. 15, 2025 /PRNewswire/ -- Surya Oil & Gas Corp. (OTCID: CNRC), ( "SOGC" or the "Company" ) formerly…

3 weeks ago

IndoStar Capital Finance reports PAT 535 crore, AUM 7,783 crore, Disbursement 858 crore

MUMBAI, India, Aug. 14, 2025 /PRNewswire/ -- IndoStar, a middle-layered non-banking finance company (NBFC) registered with the Reserve Bank of India, announced its…

4 weeks ago

Nexteer Reports Strong First-Half 2025 Results

Driven by Growth with China OEMs, Technology Leadership & Strategic Expansion   AUBURN HILLS, Mich., Aug. 13, 2025 /PRNewswire/ --…

4 weeks ago

Milestone Scientific Schedules Second Quarter 2025 Financial Results and Business Update Conference Call

August 13, 2025 11:45 ET  | Source: Milestone Scientific, Inc. ROSELAND, N.J., Aug. 13, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific…

4 weeks ago

Satellogic Reports Second Quarter Financial Results

27% Increase in Revenue to $4.4 million Coupled with 41% Decrease in Operating Costs and Expenses in 2Q 2025 Poised…

4 weeks ago

Eupraxia Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update

Announced first patient dosed in the Phase 2b placebo-controlled portion of the EP-104GI RESOLVE trial with topline data expected in…

4 weeks ago